BSECompany Update25 Jul 2026 · 25 Jul 2026, 07:21 pm

Ms. Vaishnavi Sharma, Company Secretary and Compliance officer of the Company has tendered resignation and the same is intimated herewith.

Dolphin Medical Services Ltd · 526504

✦ AI SummaryMgmt Change

Dolphin Medical Services Ltd announced the resignation of its Company Secretary and Compliance Officer, Ms. Vaishnavi Sharma, effective July 24, 2026. The Board of Directors accepted her resignation and appreciated her valuable services during her tenure.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern6/10
Regulatory Risk3/10
Balance Sheet Risk4/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Dolphin Medical Services Ltd - 526504 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer

Attachments (1)

📄

89156853-a3d4-445c-931b-61d3d3cffb8e.pdf

pdf

Download →
View document text
Date: July 25, 2026 BSE Limited Phiroze Jeejeebhoy Towers Dalal Street Mumbai – 400 001 Scrip Code: 526504 Symbol: DOLPHMED Subject: Outcome of the Board Meeting – Intimation of Resignation of Company Secretary cum Compliance Officer and Chief Financial Officer (CFO) pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir/Madam, Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations"), and SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, we wish to inform you that the Board of Directors of the Company, at its meeting held on July 25, 2026, based on the recommendations of the Nomination and Remuneration Committee and the Audit Committee, has considered and approved/noted the following: 1. Accepted the resignation of Mr. Vaishnavi Sharma from the office of Company Secretary cum Compliance Officer & Chief Financial Officer of the Company with effect from the close of business hours on [Effective Date]. The Board placed on record its sincere appreciation for the valuable services rendered by Mr. Vaishnavi Sharma during his tenure with the Company. The disclosures required under Regulation 30 read with Schedule III, Part A, Para A(7) of the SEBI Listing Regulations and the aforesaid SEBI Circular are enclosed herewith as Annexure–A. The meeting of the Board of Directors commenced at 4:30 P.M. (IST) and concluded at 5:00 P.M. (IST). Kindly take the above information on record. Thanking you. Yours faithfully, For Dolphin Medical Services Limited Director Rajesh Kumar Mallour DIN: 08125774 Encl.: Annexure–A Disclosure pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015 read with applicable circulars. Annexure - A Sr No. Particulars Details 1. Reasons for change viz., appointment, Resignation as Company Secretary and CFO resignation, removal, death or otherwise 2. Date of appointment/ cessation (as 24th July, 2026 applicable) & terms of appointment 3. Brief profile (in case of appointment) Not Applicable 4. Disclosure of relationships between Not applicable directors (in case of appointment of a director);